Fig. 6From: Variability of noninvasive MRI and biological markers in compensated cirrhosis: insights for assessing disease progressionELF score, Fibroscan® LSM and liver T1 for the stable compensated cirrhosis control patients who completed all three annual follow-up scans: a individual subject percentage change from baseline values at year 1, year 2, and year 3; b group percentage change from baseline values at year 1, year 2, and year 3. Bars indicate the interquartile range and bold line shows the median percentage change. There was no significant difference from baseline (p > 0.05 Bonferroni-corrected); c Year-to-year coefficient of variation (CoVT) in magnetic resonance imaging measures. Bars indicate the interquartile range and the horizontal bold line shows the median CoV, dots represent outliers. ELF Enhanced liver fibrosis, LSM Liver stiffness measureBack to article page